...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >DEVELOPMENT OF ZOLMITRIPTAN GEL FOR NASAL ADMINISTRATION
【24h】

DEVELOPMENT OF ZOLMITRIPTAN GEL FOR NASAL ADMINISTRATION

机译:佐米普坦凝胶用于鼻内给药的开发

获取原文

摘要

Development of thermoreversible zolmitriptan nasal gel were aimed to improve absorption and patient compliance. In the present research work, mixture of pluronic F-127 (Poloxamer 407) and pluronic F -68 (Poloxamer 188) were used to confer temperature – sensitive gelation property. To modulate the gel strength and bioadhesive force for zolmitriptan nasal gel, bioadhesive polymers such as sodium alginate, sodium carboxymethyl cellulose and polyvinyl pyrrolidone (PVP K–25) were investigated. Incorporation of 2.5 % w/w zolmitriptan in the nasal gel showed no effect on the gelation temperature of the pluronic mixtures, while addition of the bioadhesive polymers had showed increase in gelatio0n temperature. On the other hand these polymers reinforced the gel strength and the bioadhesive force of the prepared nasal gel formulation. The effect was most pronounced with sodium alginate. Increasing the concentration of bioadhesive polymers retarded the release of sumatriptan from the pluronic gel. PVP had less effect on the drug release. Histopathological examination of sheep nasal mucosa with control and optimized formulation did not show any histological damage to the nasal tissue
机译:热可逆佐米曲普坦鼻凝胶的开发旨在改善吸收和患者依从性。在当前的研究工作中,普鲁尼克F-127(Poloxamer 407)和普鲁尼克F -68(Poloxamer 188)的混合物用于赋予温度敏感性胶凝性能。为了调节佐米曲普坦鼻凝胶的凝胶强度和生物粘附力,研究了生物粘附性聚合物,例如海藻酸钠,羧甲基纤维素钠和聚乙烯吡咯烷酮(PVP K-25)。在鼻凝胶中掺入2.5%w / w的佐米曲普坦对普朗尼克混合物的凝胶化温度没有影响,而添加生物粘附性聚合物则显示凝胶化温度增加。另一方面,这些聚合物增强了所制备的鼻凝胶制剂的凝胶强度和生物粘附力。海藻酸钠的效果最明显。增加生物粘附性聚合物的浓度会阻止舒马曲坦从普鲁尼克凝胶中的释放。 PVP对药物释放的影响较小。对照和优化配方对绵羊鼻黏膜的组织病理学检查未显示对鼻组织的任何组织学损害

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号